ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 128 filers reported holding ACCELERATE DIAGNOSTICS INC in Q2 2020. The put-call ratio across all filers is 1.06 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,557,000 | -48.7% | 427,500 | -27.1% | 0.11% | -55.4% |
| Q2 2020 | $8,891,000 | +77.9% | 586,500 | -2.2% | 0.25% | +18.0% |
| Q1 2020 | $4,998,000 | -50.7% | 600,000 | 0.0% | 0.21% | -46.2% |
| Q4 2019 | $10,140,000 | +9.2% | 600,000 | +20.0% | 0.39% | +5.4% |
| Q3 2019 | $9,285,000 | -9.8% | 500,000 | +11.1% | 0.37% | -10.6% |
| Q2 2019 | $10,296,000 | -2.0% | 450,000 | -10.0% | 0.42% | -3.0% |
| Q1 2019 | $10,510,000 | +82.8% | 500,000 | 0.0% | 0.43% | +101.4% |
| Q4 2018 | $5,750,000 | -74.9% | 500,000 | -50.0% | 0.21% | -64.4% |
| Q3 2018 | $22,950,000 | +2.9% | 1,000,000 | 0.0% | 0.60% | +26.2% |
| Q2 2018 | $22,300,000 | +95.2% | 1,000,000 | +100.0% | 0.47% | +231.5% |
| Q1 2018 | $11,425,000 | -12.8% | 500,000 | 0.0% | 0.14% | -27.8% |
| Q4 2017 | $13,100,000 | +191.8% | 500,000 | +150.0% | 0.20% | +157.1% |
| Q3 2017 | $4,490,000 | -17.9% | 200,000 | 0.0% | 0.08% | -19.8% |
| Q2 2017 | $5,470,000 | – | 200,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 4,387,590 | $46,772,000 | 15.62% |
| ORACLE INVESTMENT MANAGEMENT INC | 4,091,749 | $43,618,000 | 5.75% |
| GRIFFIN ASSET MANAGEMENT, INC. | 1,439,613 | $15,346,000 | 2.36% |
| Selkirk Management LLC | 348,805 | $3,718,000 | 1.18% |
| Chicago Capital, LLC | 1,966,891 | $20,967,000 | 1.08% |
| Trellus Management Company, LLC | 46,834 | $499,000 | 0.51% |
| Cannell & Co. | 1,118,439 | $11,923,000 | 0.44% |
| OAKTOP CAPITAL MANAGEMENT II, L.P. | 155,000 | $1,652,000 | 0.36% |
| Belpointe Asset Management LLC | 419,406 | $3,982,000 | 0.27% |
| TCI Wealth Advisors, Inc. | 55,586 | $593,000 | 0.23% |